Zobrazeno 1 - 10 of 25 pro vyhledávání: '"J Roberston"'
1
Abstract P2-07-05: A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced stage breast cancer treated with first-line endocrine therapy
Autor: Maura N. Dickler, Jonas Bergh, William E. Barlow, S. Loibl, M. Martin, M-Yc Polley, Rita S. Mehta, J de la Haba, Kathleen S. Tenner, Hongfang Liu, Matthew P. Goetz, J Roberston, S.R.D. Johnston
Publikováno v: Cancer Research. 79:P2-07
Purpose: Endocrine based therapy is an effective strategy to manage hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC). However, nearly all patients exhibit/develop either de novo or
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7cb86c8f88d40b8ad3a936d8a76e841c
https://doi.org/10.1158/1538-7445.sabcs18-p2-07-05
Zobrazit plný text záznamu
2
Molybdenum stable isotope fractionation during the precipitation of powellite (CaMoO4) and wulfenite (PbMoO4)
Autor: J. Roberston, Roger Beckie, K. U. Mayer, Dominique Weis, E.K. Skierszkan
Publikováno v: Geochimica et Cosmochimica Acta. 244:383-402
Laboratory batch experiments were conducted to study Mo isotope fractionation during the precipitation of powellite (CaMoO4) and wulfenite (PbMoO4). These minerals act as important sinks of dissolved Mo, especially in alkaline-pH mine drainage. Their
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef7179eb9ef0f3b88f9c1ebe2b01f3da
https://doi.org/10.1016/j.gca.2018.09.030
Zobrazit plný text záznamu
3
CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression
Autor: Matthew J. Roberston, M. David Stewart, Bradley K. McConnell, Vladimir N. Potaman, Robert J. Schwartz, Fan Zhang, Suchi Raghunathan
Publikováno v: FASEB J
Muscle wasting, or muscle atrophy, can occur with age, injury, and disease; it affects the quality of life and complicates treatment. Insulin-like growth factor 1 (IGF1) is a key positive regulator of muscle mass. The IGF1/Igf1 gene encodes multiple
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660960a1131ecc2d979a72a6d5a2472f
https://pubmed.ncbi.nlm.nih.gov/31914652
Zobrazit plný text záznamu
7
Phase I clinical evaluation of AZD2171, a highly potent VEGF receptor tyrosine kinase inhibitor, in patients with advanced tumors
Autor: J. Roberston, Ute Zirrgiebel, Ralph Strecker, J. Drevs, P. Siegert, Thomas A. Puchalski, Michael Medinger, Clemens Unger, Klaus Mross, N. Fernandes
Publikováno v: Journal of Clinical Oncology. 23:3002-3002
3002 Background: AZD2171 is a highly potent and orally available inhibitor of VEGF receptor tyrosine kinase activity, and has shown antitumor activity in a wide range of tumor xenograft models. This Phase I trial was designed to assess the safety, to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a17b373bbef9a7e6bd75b8eca8dfe18
https://doi.org/10.1200/jco.2005.23.16_suppl.3002
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje